Clinical experience with non-nucleoside reverse transcriptase inhibitors: L-697,661 and nevirapine.
Kilby
J M
JM
Division of Infectious Diseases, University of Alabama at Birmingham, USA.
Saag
M S
MS
D001583:Benzoxazoles / Q000494:pharmacology / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D054303:HIV Reverse Transcriptase; D015497:HIV-1 / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D019829:Nevirapine; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use*; D011728:Pyridones / Q000494:pharmacology / Q000627:therapeutic use*; D012194:RNA-Directed DNA Polymerase / Q000378:metabolism*; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*
D001583:Benzoxazoles; D011725:Pyridines; D011728:Pyridones; D018894:Reverse Transcriptase Inhibitors; C076516:L-697661; D019829:Nevirapine; D054303:HIV Reverse Transcriptase; D012194:RNA-Directed DNA Polymerase